OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review
Nina Schimmers, Joost J. Breeksema, Sanne Y. Smith-Apeldoorn, et al.
Psychopharmacology (2021) Vol. 239, Iss. 1, pp. 15-33
Closed Access | Times Cited: 111
Nina Schimmers, Joost J. Breeksema, Sanne Y. Smith-Apeldoorn, et al.
Psychopharmacology (2021) Vol. 239, Iss. 1, pp. 15-33
Closed Access | Times Cited: 111
Showing 1-25 of 111 citing articles:
Novel and emerging treatments for major depression
Steven Marwaha, Edward Palmer, Trisha Suppes, et al.
The Lancet (2022) Vol. 401, Iss. 10371, pp. 141-153
Open Access | Times Cited: 304
Steven Marwaha, Edward Palmer, Trisha Suppes, et al.
The Lancet (2022) Vol. 401, Iss. 10371, pp. 141-153
Open Access | Times Cited: 304
Towards an understanding of psychedelic-induced neuroplasticity
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 173
Abigail E. Calder, Gregor Hasler
Neuropsychopharmacology (2022) Vol. 48, Iss. 1, pp. 104-112
Open Access | Times Cited: 173
Anxiety and depression in adult cancer patients: ESMO Clinical Practice Guideline
Luigi Grassi, Rosangela Caruso, Michelle B. Riba, et al.
ESMO Open (2023) Vol. 8, Iss. 2, pp. 101155-101155
Open Access | Times Cited: 98
Luigi Grassi, Rosangela Caruso, Michelle B. Riba, et al.
ESMO Open (2023) Vol. 8, Iss. 2, pp. 101155-101155
Open Access | Times Cited: 98
Psychedelic therapy for depressive symptoms: A systematic review and meta-analysis
Kwonmok Ko, Emma I Kopra, Anthony J. Cleare, et al.
Journal of Affective Disorders (2022) Vol. 322, pp. 194-204
Closed Access | Times Cited: 84
Kwonmok Ko, Emma I Kopra, Anthony J. Cleare, et al.
Journal of Affective Disorders (2022) Vol. 322, pp. 194-204
Closed Access | Times Cited: 84
Therapeutic effect of psilocybin in addiction: A systematic review
Pim B. van der Meer, Juan José Fuentes, Ad A. Kaptein, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 72
Pim B. van der Meer, Juan José Fuentes, Ad A. Kaptein, et al.
Frontiers in Psychiatry (2023) Vol. 14
Open Access | Times Cited: 72
The therapeutic potential of psilocybin: a systematic review
Jan van Amsterdam, Wim van den Brink
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 833-840
Closed Access | Times Cited: 58
Jan van Amsterdam, Wim van den Brink
Expert Opinion on Drug Safety (2022) Vol. 21, Iss. 6, pp. 833-840
Closed Access | Times Cited: 58
Pattern breaking: a complex systems approach to psychedelic medicine
Inês Hipólito, Jonas Mago, Fernando E. Rosas, et al.
Neuroscience of Consciousness (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 38
Inês Hipólito, Jonas Mago, Fernando E. Rosas, et al.
Neuroscience of Consciousness (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 38
Alleviating anxiety and taming trauma: Novel pharmacotherapeutics for anxiety disorders and posttraumatic stress disorder
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
Nicolas Singewald, Simone B. Sartori, Andreas Reif, et al.
Neuropharmacology (2023) Vol. 226, pp. 109418-109418
Open Access | Times Cited: 37
Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics
Alaina M. Jaster, Javier González‐Maeso
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3595-3612
Open Access | Times Cited: 22
Alaina M. Jaster, Javier González‐Maeso
Molecular Psychiatry (2023) Vol. 28, Iss. 9, pp. 3595-3612
Open Access | Times Cited: 22
Psychological flexibility as a mechanism of change in psilocybin-assisted therapy for major depression: results from an exploratory placebo-controlled trial
Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Jordan Sloshower, Richard J. Zeifman, Jeffrey Guss, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
CUIDADOS PALIATIVOS NO BRASIL
Rafael Fortes, Izabela Carneiro Neves, Júlia Silva Costa, et al.
Editora Conhecimento Livre eBooks (2024)
Open Access | Times Cited: 10
Rafael Fortes, Izabela Carneiro Neves, Júlia Silva Costa, et al.
Editora Conhecimento Livre eBooks (2024)
Open Access | Times Cited: 10
Psychedelics for the Treatment of Psychiatric Disorders: Interpreting and Translating Available Evidence and Guidance for Future Research
Roger S. McIntyre, Angela T.H. Kwan, Rodrigo B. Mansur, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 21-32
Closed Access | Times Cited: 1
Roger S. McIntyre, Angela T.H. Kwan, Rodrigo B. Mansur, et al.
American Journal of Psychiatry (2025) Vol. 182, Iss. 1, pp. 21-32
Closed Access | Times Cited: 1
Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness
William E. Rosa, Zachary Sager, Megan E. Miller, et al.
Journal of Palliative Medicine (2022) Vol. 25, Iss. 8, pp. 1273-1281
Open Access | Times Cited: 35
William E. Rosa, Zachary Sager, Megan E. Miller, et al.
Journal of Palliative Medicine (2022) Vol. 25, Iss. 8, pp. 1273-1281
Open Access | Times Cited: 35
Compassion as a Skill: A Comparison of Contemplative and Evolution-Based Approaches
Paul Gilbert, William Van Gordon
Mindfulness (2023) Vol. 14, Iss. 10, pp. 2395-2416
Open Access | Times Cited: 18
Paul Gilbert, William Van Gordon
Mindfulness (2023) Vol. 14, Iss. 10, pp. 2395-2416
Open Access | Times Cited: 18
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 18
Side-effects of mdma-assisted psychotherapy: a systematic review and meta-analysis
Julia Colcott, Alexandre Guerin, Olivia Carter, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 8, pp. 1208-1226
Open Access | Times Cited: 7
Julia Colcott, Alexandre Guerin, Olivia Carter, et al.
Neuropsychopharmacology (2024) Vol. 49, Iss. 8, pp. 1208-1226
Open Access | Times Cited: 7
How Do Psychedelics Reduce Fear of Death?
Chris Letheby
Neuroethics (2024) Vol. 17, Iss. 2
Open Access | Times Cited: 6
Chris Letheby
Neuroethics (2024) Vol. 17, Iss. 2
Open Access | Times Cited: 6
Ayahuasca's therapeutic potential: What we know – and what not
Lucas Oliveira Maia, Dimitri Daldegan‐Bueno, Isabel Wießner, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 45-61
Closed Access | Times Cited: 27
Lucas Oliveira Maia, Dimitri Daldegan‐Bueno, Isabel Wießner, et al.
European Neuropsychopharmacology (2022) Vol. 66, pp. 45-61
Closed Access | Times Cited: 27
Can psychedelics enhance group psychotherapy? A discussion on the therapeutic factors
Polina Ponomarenko, Federico Seragnoli, Abigail E. Calder, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 660-678
Open Access | Times Cited: 15
Polina Ponomarenko, Federico Seragnoli, Abigail E. Calder, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 660-678
Open Access | Times Cited: 15
Psychedelic treatments for mental health conditions pose challenges for informed consent
Carolina Seybert, Gonçalo Cotovio, Luís Madeira, et al.
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2167-2170
Closed Access | Times Cited: 15
Carolina Seybert, Gonçalo Cotovio, Luís Madeira, et al.
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2167-2170
Closed Access | Times Cited: 15
The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics
Marco Onofrj, Mirella Russo, Stefano Delli Pizzi, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Marco Onofrj, Mirella Russo, Stefano Delli Pizzi, et al.
Translational Psychiatry (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 15
Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022
Xuepeng Jing, Nicholas Hoeh, David B Menkes
Palliative & Supportive Care (2023) Vol. 21, Iss. 4, pp. 697-704
Open Access | Times Cited: 14
Xuepeng Jing, Nicholas Hoeh, David B Menkes
Palliative & Supportive Care (2023) Vol. 21, Iss. 4, pp. 697-704
Open Access | Times Cited: 14
Ketamine and Ketamine-Assisted Psychotherapy for Psychiatric and Existential Distress in Patients with Serious Medical Illness: A Narrative Review
Roxanne Sholevar, William Kromka, Yvan Beaussant
Journal of Palliative Medicine (2025)
Closed Access
Roxanne Sholevar, William Kromka, Yvan Beaussant
Journal of Palliative Medicine (2025)
Closed Access
Palliative Care, Psychological Interventions, Personalized Medicine: The Triple "P" Hypothesis For Enhancing Quality of Life in Palliative Care
Danial Nejadmasoom, Arvin Mirshahi
Qeios (2025) Vol. 7, Iss. 1
Open Access
Danial Nejadmasoom, Arvin Mirshahi
Qeios (2025) Vol. 7, Iss. 1
Open Access
